Associations of urinary, glomerular, and tubular markers with the development of diabetic kidney disease in type 2 diabetes patients

Journal of Clinical Laboratory Analysis

Volumn 32, Issue 1, 2018, Pages

  Jiang, Xu ^a,b   Zhang, Qian ^a   Wang, Hua Bin ^c   Cui, Xiao Fan ^b   Liu, Rui ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN UNION MEDICAL CENTER   (China)

^c Department of Clinical Pharmacy Central Hospital of Jinhua City   (China)

Author keywords

albuminuria; diabetic kidney disease; glomerular filtration rate; 1 microglobulin; 2 microglobulin

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; BETA 2 MICROGLOBULIN; HEMOGLOBIN A1C; IMMUNOGLOBULIN G; TRANSFERRIN; ALPHA GLOBULIN; ALPHA-1-MICROGLOBULIN; BIOLOGICAL MARKER;

AGE DISTRIBUTION; ALBUMINURIA; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; BODY MASS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DISEASE MARKER; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HUMAN; IMMUNOGLOBULIN G URINE LEVEL; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; TRANSFERRIN URINE LEVEL; URINALYSIS; URINE LEVEL; AGED; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; GLOMERULUS FILTRATION RATE; MIDDLE AGED; REGRESSION ANALYSIS; URINE;

AGED; ALBUMINURIA; ALPHA-GLOBULINS; ANALYSIS OF VARIANCE; BETA 2-MICROGLOBULIN; BIOMARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 85014070225     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.22191     Document Type: Article

References (22)

1. KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(2 suppl 2):S12-S154.
2. Basevi V, Di Mario S, Morciano C, et al. Comment on: American Diabetes Association. Standards of medical care in diabetes–2011. Diabetes Care. 2011;34(suppl 1):S11-S61.
3. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17-28.
4. Nauta FL, Scheven L, Meijer E, et al. Glomerular and tubular damage markers in individuals with progressive albuminuria. Clin J Am Soc Nephrol. 2013;8:1106-1114.
5. Brantsma AH, Bakker SJ, de Zeeuw D, et al. Extended prognostic value of urinary albumin excretion for cardiovascular events. J Am Soc Nephrol. 2008;19:1785-1791.
6. El Nahas M. Cardio-Kidney-Damage: a unifying concept. Kidney Int. 2010;78:14-18.
7. Bonventre JV. Can we target tubular damage to prevent renal function decline in diabetes? Semin Nephrol. 2012;32:452-462.
8. Yu H, Yanagisawa Y, Forbes MA, et al. Alpha-1-microglobulin: an indicator protein for renal tubular function. J Clin Pathol. 1983;36:253-259.
9. Hong CY, Hughes K, Chia KS, et al. Urinary alpha1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in Singapore. Diabetes Care. 2003;26:338-342.
10. Schutte E, Gansevoort RT, Benner J, et al. Will the future lie in multitude? A critical appraisal of biomarker panel studies on prediction of diabetic kidney disease progression Nephrol Dial Transplant. 2015;30(suppl 4):iv96-iv104.
11. Perkins BA, Krolewski AS. Early nephropathy in type 1 diabetes: the importance of early renal function decline. Curr Opin Nephrol Hypertens. 2009;18:233-240.
12. Jerums G, Panagiotopoulos S, Premaratne E, et al. Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis. Am J Nephrol. 2008;28:614-627.
13. Andrassy KM. Comments on ‘KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease’. Kidney Int. 2013;84:622-623.
14. Komenda P, Rigatto C, Tangri N. Estimated glomerular filtration rate and albuminuria: diagnosis, staging, and prognosis. Curr Opin Nephrol Hypertens. 2014;23:251-257.
15. Narita T, Hosoba M, Kakei M, et al. Increased urinary excretions of immunoglobulin g, ceruloplasmin, and transferrin predict development of microalbuminuria in patients with type 2 diabetes. Diabetes Care. 2006;29:142-144.
16. Ohara N, Hanyu O, Hirayama S, et al. Hypertension increases urinary excretion of immunoglobulin G, ceruloplasmin and transferrin in normoalbuminuric patients with type 2 diabetes mellitus. J Hypertens. 2014;32:432-438.
17. Kazumi T, Hozumi T, Ishida Y, et al. Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes. Diabetes Care. 1999;22:1176-1180.
18. Mohan S, Kalia K, Mannari J. Association between urinary IgG and relative risk for factors affecting proteinuria in type 2 diabetic patients. Indian J Clin Biochem. 2012;27:333-339.
19. Shore N, Khurshid R, Saleem M. Alpha-1 microglobulin: a marker for early detection of tubular disorders in diabetic nephropathy. J Ayub Med Coll Abbottabad. 2010;22:53-55.
20. Petrica L, Petrica M, Vlad A, et al. Proximal tubule dysfunction is dissociated from endothelial dysfunction in normoalbuminuric patients with type 2 diabetes mellitus: a cross-sectional study. Nephron Clin Pract. 2011;118:c155-c164.
21. Petrica L, Petrica M, Vlad A, et al. Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial. Wien Klin Wochenschr. 2009;121:765-775.
22. Petrica L, Vlad A, Petrica M, et al. Pioglitazone delays proximal tubule dysfunction and improves cerebral vessel endothelial dysfunction in normoalbuminuric people with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2011;94:22-32.